Assiut University, Egypt

Author Profile

🎓Academic and Professional Background

Mahmoud Abd-Elkareem Mahmoud is a Professor in the Department of Cell and Tissues at the Faculty of Veterinary Medicine, Assiut University. He has established himself as a distinguished researcher in the field of reproductive biology and histopathology. Over the years, he has published numerous high-impact articles in international journals, contributing significantly to the scientific community. In addition to his research, he serves as an editor and reviewer for various renowned international journals, ensuring the dissemination of high-quality scientific knowledge.

🔬Research Interests

His research expertise spans multiple areas within biomedical sciences. His primary interests include reproductive biology, particularly focusing on the development of the ovary and embryology. He has also extensively studied stem cells, applying advanced techniques such as electron microscopy, histopathology, and immunohistochemistry. His work further extends into cytopathology and frozen section analysis, offering insights into cellular structures and disease pathology.

📑Ongoing Research & Projects

Currently, Mahmoud Abd-Elkareem is leading an innovative research project on the effects of Miswak aqueous extract on reproductive performance. His study explores the therapeutic potential of Salvadora persica (Miswak), particularly in adult rats exposed to excess testosterone, with a special focus on its protective effects on the brain and testis. His research aims to uncover natural remedies for reproductive and neurological health challenges, advancing the field of alternative medicine and toxicology.

🏅Professional Memberships

Mahmoud Abd-Elkareem actively participates in several professional organizations, contributing to quality assurance and scientific advancements in veterinary medicine. He is a member of the Quality Assurance and Accreditation Project and the Quality Assurance Unit at the Faculty of Veterinary Medicine, Assiut University. Additionally, he is affiliated with the Egyptian Society of Histology & Cytology, further strengthening his engagement with the global scientific community.

🌍Impact and Contributions

With his extensive knowledge and commitment to scientific research, Mahmoud Abd-Elkareem continues to make remarkable contributions to the fields of histopathology, reproductive biology, and cytopathology. His dedication to academic excellence and innovative research has positioned him as a leading figure in veterinary and biomedical sciences.

Notable Publications📝

📝Antioxidant and cytoprotective effects of Nigella sativa L. seeds on the testis of monosodium glutamate challenged rats

Authors: Abd-Elkareem, M.; Abd El-Rahman, M.A.M.; Khalil, N.S.A.; Amer, A.S.
Journal: Scientific Reports
Year: 2021

📝Broiler welfare is preserved by long-term low-dose oral exposure to zinc oxide nanoparticles: preliminary study

Authors: Mahmoud, M.A.M.; Yahia, D.; Abdel-Magiud, D.S.; Darwish, M.H.A.; Abd-Elkareem, M.; Mahmoud, U.T.
Journal: Nanotoxicology
Year: 2021

📝Prebiotics reduce feather pecking behavior, and improve trace element profile and redox balance in Mule ducks

Authors: Mahmoud, U.T.; Mahmoud, M.A.M.; Abd-Elkareem, M.; Ahmed, F.A.M.; Khalil, N.S.A.
Journal: Journal of Veterinary Behavior
Year: 2021

📝Cytoprotective effect of Nigella sativa seed on 4-nonylphenol-induced renal damage in the African catfish (Clarias gariepinus)

Authors: Abd-Elkareem, M.; Abou Khalil, N.S.; Sayed, A.E.-D.H.
Journal: Chemosphere
Year: 2020

📝High-Payload chitosan microparticles for the colonic delivery of quercetin: Development and in-vivo evaluation in a rabbit colitis model

Authors: Helmy, A.M.; Elsabahy, M.; Abd-Elkareem, M.; Ibrahim, E.A.; Soliman, G.M.
Journal: Journal of Drug Delivery Science and Technology
Year: 2020

Mr. Matieta Yemene Valaire -Pharmacology- Best Researcher Award

Posted on 24/02/2025 by sciencefather

Mr. Matieta Yemene Valaire –Pharmacology- Best Researcher Award

university of Dschang – Cameroon

Author Profile

Scopus

🎓 Educational Background

In 2021, Matieta Yemene Valaire obtained a Master of Science (MSc) in Biochemistry (Pharmacology) from the University of Dschang, Faculty of Science, DSST, Department of Biochemistry. They graduated with Distinction: Good. Their master’s thesis, titled “Evaluation of the antiklebsiella activity of methanol extracts of eight food plants from Cameroon and the effect of their combinations with usual antibiotics and PAβN,” focused on antimicrobial properties of natural extracts. This research was supervised by Pr. MBAVENG TSAFACK Armelle. In 2019, they earned a Bachelor of Science (BSc) in Biochemistry (Pharmacology) from the University of Dschang, Faculty of Science, Department of Biochemistry. They completed their undergraduate studies with Distinction: Good Enough, showcasing their dedication and academic excellence in pharmacological biochemistry.

🏆 Honors and Awards

Matieta Yemene Valaire has received multiple academic and research accolades throughout their career. In 2019, they were recognized as the valedictorian of their promotion in Biochemistry (Pharmacology) at the Department of Biochemistry, University of Dschang, Cameroon. Since 2020, they have contributed to academia as a schoolteacher in Jackson Group Repetition Class at the University of Dschang, mentoring students in biochemistry and pharmacology. In 2021, their hard work and commitment to academic excellence earned them the title of second-best student in Biochemistry (Pharmacology specialty) at the Department of Biochemistry, University of Dschang. In 2023, they were honored with the prestigious TWAS-DBT 2023 Postgraduate Fellowship Programme Award, recognizing their outstanding research contributions in the field of biochemistry and microbiology.

🧪 Techniques and Skills

Matieta Yemene Valaire possesses a diverse set of laboratory skills and expertise in microbiology, pharmacology, and biochemical research. They have hands-on experience in bacteria culture techniques using different culture media, contributing to research on plant-derived anticancer substances. Their skills extend to plant extraction and phytochemical screening techniques, which are essential for identifying bioactive compounds with potential pharmaceutical applications. Additionally, they are proficient in antibiogram techniques and microdilution methods, which are critical for evaluating the antimicrobial activity of natural products. Matieta is also skilled in blood sample preparation and cell counting from laboratory animals, a fundamental technique in pharmacological and toxicological studies. They have expertise in serum preparation and biochemical parameter dosage, which are essential for analyzing the physiological effects of pharmacological agents. Furthermore, they have conducted research on cytotoxicity, acute and sub-chronic toxicities, and explored the mechanism of action of plant extracts on bacteria, contributing to the growing body of knowledge in natural antimicrobial compounds.

Notable Publication📄

📄Cytotoxicity, acute and subchronic toxicity of the methanol extract from the fruits of Psorospermun febrifugum Spach (Hypericaceae) in Wistar albino rats

Authors: J.F. Megaptche, R.D.T. Nago, S.B. Tankeo, T.H. Efferth, V. Kuete, et al.
Journal: South African Journal of Botany
Year: 2025

Mrs. Feifei Song | immunotherapy | Best Researcher Award

Posted on 17/01/202517/01/2025 by sciencefather

Mrs. Feifei Song | immunotherapy | Best Researcher Award

Mrs. Feifei Song | UNC-CH, China

Professional Profiles

Google Scholar

Scopus

🎓Academic and Professional Background

Feifei Song earned a Ph.D. from Wuhan University in China, where she specialized in liver cancer research. During this time, she published influential studies that unveiled the pivotal roles of microRNAs in liver cancer progression and identified novel therapeutic targets. Since 2019, she has served as a Postdoctoral Research Associate at UNC-CH, focusing on advancing CAR-T cell therapy for hematologic malignancies and expanding its application to solid tumors. Her innovative work includes systematically screening kinase inhibitors, identifying three that significantly preserve the stem-cell-like phenotype of CAR-T cells during manufacturing, which is poised to improve therapeutic outcomes.

🔬Areas of Research

Feifei Song’s research lies at the intersection of cancer biology, immunotherapy, and CAR-T cell optimization. She is dedicated to investigating novel therapeutic targets for Hepatocellular Carcinoma (HCC), focusing on uncovering pathways and molecules that drive tumor development and progression. Her work also emphasizes advancing immunotherapy approaches to improve the effectiveness of treatments for various cancers, including solid tumors. Additionally, Feifei is committed to developing innovative strategies to optimize CAR-T cell manufacture and functionality, ensuring these engineered immune cells maintain their stem-cell-like phenotype and enhanced persistence during and after treatment.

Publications Top Noted📝

4-1BB-encoding CAR causes cell death via sequestration of the ubiquitin-modifying enzyme A20

Authors: Dou, Z.; Bonacci, T.R.; Shou, P.; ...; Dotti, G.; Zhou, X.

Journal: Cellular and Molecular Immunology

Year: 2024

Implantable CAR T cell factories enhance solid tumor treatment

Authors: Pandit, S.; Agarwalla, P.; Song, F.; ...; Dotti, G.; Brudno, Y.

Journal: Biomaterials

Year: 2024

Preclinical evaluation of B7-H3-specific chimeric antigen receptor T cells for the treatment of acute myeloid leukemia

Authors: Lichtman, E.I.; Du, H.; Shou, P.; ...; Savoldo, B.; Dotti, G.

Journal: Clinical Cancer Research

Year: 2021

Prof Dr. bing han | Medicinal Chemistry | Outstanding Scientist Award

Posted on 06/01/2025 by sciencefather

Prof Dr. bing han | Medicinal Chemistry | Outstanding Scientist Award

Prof Dr. bing han, Peking University School and Hospital of Stomatology, China

Professional Profiles

Scopus

Orcid

🎓 Academic Qualifications

Professor Bing Han’s academic journey began at Peking University where he completed his Consecutive Degree Program (Bachelor and MD) at the School of Stomatology from 1997 to 2004. He then pursued a Ph.D. at the same institution, graduating in 2007. His education laid the foundation for a highly successful career in orthodontics and craniofacial research.

🏆 Professional Achievements

Professor Han’s dedication to advancing the field of orthodontics is evident through his prestigious roles and recognition. In 2021, he was named a Leading Talent of Science and Technology Innovation under the National Ten Thousand Talents Plan. His current role as Professor and Vice Director of the Department of Orthodontics at Peking University School and Hospital of Stomatology has been ongoing since 2018. Previously, he served as an Associate Professor (2012-2018) and held the role of Lecturer and Doctor in Charge from 2007 to 2012.

🔬 Research Interests and Contributions

Professor Bing Han has conducted pioneering research in craniofacial growth and development, bone tissue engineering, stem cells, orthodontics, and biomaterials. His interdisciplinary approach blends clinical expertise with innovative research to address fundamental challenges in the field. His work has contributed significantly to the understanding of bone regeneration and the application of biomaterials in orthodontics, shaping advancements in both medical and dental sciences.

🏅 Honors and Awards

Professor Bing Han has received numerous prestigious accolades in recognition of his groundbreaking contributions to orthodontics, research, and education. He was honored under the National High-Level Talents Special Support Program as a Leading Talent of Technological Innovation, a testament to his influence in advancing dental sciences. Additionally, he was selected for the Innovation Leadership Program for Young and Middle-aged Scientists, showcasing his role as a visionary in scientific research and technology.

Among his notable achievements, Professor Han was awarded the Prize for Outstanding Doctor of Peking University, reflecting his excellence in both clinical practice and academia. His innovative work has also been recognized with the Second Prize of the Beijing Science and Technology Award and the Second Prize of the Chinese Stomatology Science and Technology Award, further solidifying his reputation as a leading figure in the field of orthodontics. These accolades underscore his exceptional dedication to advancing knowledge and improving clinical outcomes in stomatology.

Publications Top Noted📝

Recent Progress in the Auxiliary Phase Enhanced Flexible Piezocomposites

Authors: Gao, X., Zheng, M., Hou, B., Wang, K., Han, B.

Journal: Energy and Environmental Materials

Year: 2025

Dynamics of the Oral Microbiome During Orthodontic Treatment and Antimicrobial Advances for Orthodontic Appliances

Authors: Niu, Q., Chen, S., Bai, R., Han, B., Yu, T.

Journal: iScience

Year: 2024

Colon-Targeted Engineered Postbiotics Nanoparticles Alleviate Osteoporosis Through the Gut-Bone Axis

Authors: Yu, T., Bai, R., Wang, Z., Nie, G., Han, B.

Journal: Nature Communications

Year: 2024

Origin of Ultrahigh-Performance Barium Titanate-Based Piezoelectrics: Stannum-Induced Intrinsic and Extrinsic Contributions

Authors: Wu, B., Zheng, H., Wu, Y.-Q., Wang, K., Han, B.

Journal: Nature Communications

Year: 2024

Network Analysis of Three-Dimensional Hard-Soft Tissue Relationships in the Lower 1/3 of the Face: Skeletal Class I-Normodivergent Malocclusion Versus Class II-Hyperdivergent Malocclusion

Authors: Wang, T., Nie, K., Fan, Y., Song, G., Xu, T.

Journal: BMC Oral Health

Year: 2024

Dr. Aloïse Mabondzo | drug design | Best Researcher Award

Posted on 28/12/2024 by sciencefather

Dr. Aloïse Mabondzo | drug design | Best Researcher Award

Doctorate at CEA, France

Professional Profiles

Google Scholar

Scopus

Orcid

🎓 Educational Background

Dr. Aloïse Mabondzo, has a distinguished academic foundation. He earned his Master’s degree in Molecular and Cellular Biology from the University of Strasbourg, France (1986-1989). Driven by a passion for cutting-edge research, he pursued a PhD in Virology and Immunology at the prestigious Pierre and Marie Curie University, France (1989-1993). His doctoral work focused on Active Immunotherapy using bispecific antibodies against HIV, a testament to his early commitment to tackling global health challenges.

🧪 Professional Positions

Dr. Mabondzo’s illustrious career began with a Post-doctoral Research Fellowship (1993-1997) at the CEA Neurovirology Department, where he made significant contributions to the field of neurovirology. In 1998, he joined the CEA Medicine and Healthcare Technologies Department, where he has served as Research Director and Head of the Neurovascular Unit Research and Therapeutic Innovation Laboratory. His leadership in these roles has driven breakthroughs in neurovascular research. Since 2019, Dr. Mabondzo has also been the Co-founder and Research Director of Ceres Brain Therapeutics, a startup dedicated to pioneering therapeutic innovations.

👩‍🏫 Mentoring and Supervision

Dr. Mabondzo has a proven track record as a mentor and supervisor. Over his career, he has supervised 16 PhD candidates (10 past, 6 current), 7 Postdoctoral Fellows (4 past, 3 current), and several other researchers, including 2 Research Assistants, 2 Engineers, and 2 Technicians. His mentorship has nurtured the next generation of scientists, fostering innovation and collaboration.

Publications Top Noted📄

Dodecyl creatine ester therapy: from promise to reality

Authors: Mabondzo, A.; van de Kamp, J.; Mercimek-Andrews, S.

Journal: Cellular and Molecular Life Sciences

Year: 2024

A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases

Authors: Angeli, E.; Paris, J.; Le Tilly, O.; Paintaud, G.; Bousquet, G.

Journal: Experimental Hematology and Oncology

Year: 2024

Impaired brain glucose metabolism as a biomarker for evaluation of dodecyl creatine ester in creatine transporter deficiency: Insights from patient brain-derived organoids and in vivo [18F]FDG PET imaging in a mouse model

Authors: Disdier, C.; Soyer, A.; Broca-Brisson, L.; Tournier, N.; Mabondzo, A.

Journal: Neurobiology of Disease

Year: 2024

Targeting the Multiple Complex Processes of Hypoxia-Ischemia to Achieve Neuroprotection

Authors: Maïza, A.; Hamoudi, R.; Mabondzo, A.

Journal: International Journal of Molecular Sciences

Year: 2024

Epigenetic alterations in creatine transporter deficiency: a new marker for dodecyl creatine ester therapeutic efficacy monitoring

Authors: Broca-Brisson, L.; Disdier, C.; Harati, R.; Hamoudi, R.; Mabondzo, A.

Journal: Frontiers in Neuroscience

Year: 2024